The European cardiology market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The market is mainly driven owing to the well-developed healthcare sector and considerably high healthcare expenditure and infrastructure in its economies such as Germany, UK, France and others. The major factor contributing to the European cardiology market is the rising prevalence of CVDs. Unhealthy lifestyle such as smoking, consumption of drugs and alcohol in European countries are the major factors for increasing CVD incidences among men and women. Government initiatives, programs and funding related to increasing awareness toward CVD are also contributing to the growth of the market in the region.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/european-cardiology-market
The market is segmented on the basis of Device type, drug type, mechanism, and surgeries type. Based on Device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/european-cardiology-market
The companies which are contributing to the growth of the European market include AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche AG, General Electric Co., Medtronic PLC, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Market Segmentation
European Cardiology Market by Device Type
- Angioplasty
- Cardiovascular stents
- Cardiovascular catheters
- Cardiac rhythm management
- Cardiovascular assistive devices
European Cardiology Market by Drug Type
- Antithrombotic drugs
- Antidyslipidemic drugs
- Antihypertensive drugs
- Anti-stroke drugs
European Cardiology Market by Mechanism
- Beta blockers
- Beta agonists
- Alpha blockers
- Alpha agonists
- Sodium channel blockers
- Calcium channel blockers
- Vasodilators
- Renin inhibitors
- Angiotensin receptor blockers
- Diuretics
- Thrombolytics
European Cardiology Market by Surgeries Type
- Coronary artery bypass grafting
- Transmyocardial laser revascularization
- Heart valve repair
- Arrhythmia treatment
- Aneurysm repair
- Heart transplant
Regional Analysis
- UK
- Germany
- Italy
- France
- Spain
- Rest of Europe
Company Profiles
- Abbott Laboratories
- AstraZeneca PLC
- Bayer AG
- Boehringer Ingelheim International GmbH
- Hoffmann-La Roche AG
- General Electric Co.
- Medtronic PLC
- Merck KGaA
- Novartis International AG
- Sanofi S.A.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
